294 related articles for article (PubMed ID: 30408026)
1. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10.
Tan P; Ye Y; He L; Xie J; Jing J; Ma G; Pan H; Han L; Han W; Zhou Y
PLoS Biol; 2018 Nov; 16(11):e3000051. PubMed ID: 30408026
[TBL] [Abstract][Full Text] [Related]
2. TRIM59 deficiency curtails breast cancer metastasis through SQSTM1-selective autophagic degradation of PDCD10.
Tan P; He L; Zhou Y
Autophagy; 2019 Apr; 15(4):747-749. PubMed ID: 30653426
[TBL] [Abstract][Full Text] [Related]
3. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of tripartite motif protein 59 inhibits proliferation, migration and invasion in breast cancer cells.
Zhang Y; Yang WB
Biomed Pharmacother; 2017 May; 89():462-467. PubMed ID: 28249247
[TBL] [Abstract][Full Text] [Related]
5. TRIM59 is a key regulator of growth and migration inrenal cell carcinoma.
Hu SH; Zhao MJ; Wang WX; Xu CW; Wang GD
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):68-74. PubMed ID: 28719348
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
7. TRIM59 regulates autophagy through modulating both the transcription and the ubiquitination of BECN1.
Han T; Guo M; Gan M; Yu B; Tian X; Wang JB
Autophagy; 2018; 14(12):2035-2048. PubMed ID: 30231667
[TBL] [Abstract][Full Text] [Related]
8. TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway.
Liu Y; Dong Y; Zhao L; Su L; Diao K; Mi X
Mol Carcinog; 2018 Dec; 57(12):1792-1802. PubMed ID: 30175868
[TBL] [Abstract][Full Text] [Related]
9. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression.
Wang Y; Zhou Z; Wang X; Zhang X; Chen Y; Bai J; Di W
Int J Biol Sci; 2018; 14(14):2073-2082. PubMed ID: 30585270
[TBL] [Abstract][Full Text] [Related]
10. Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation.
Sun B; Zhong FJ; Xu C; Li YM; Zhao YR; Cao MM; Yang LY
Cell Death Dis; 2021 Sep; 12(9):849. PubMed ID: 34521817
[TBL] [Abstract][Full Text] [Related]
11. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y
Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983
[TBL] [Abstract][Full Text] [Related]
12. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma.
Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T
Front Immunol; 2021; 12():637053. PubMed ID: 34108959
[TBL] [Abstract][Full Text] [Related]
13. TRIM59 promotes cell proliferation, migration and invasion in human hepatocellular carcinoma cells.
Sun G; Sui X; Han D; Gao J; Liu Y; Zhou L
Pharmazie; 2017 Nov; 72(11):674-679. PubMed ID: 29442042
[TBL] [Abstract][Full Text] [Related]
14. Tripartite Motif-Containing Protein 59 (TRIM59) Promotes Epithelial Ovarian Cancer Progression via the Focal Adhesion Kinase(FAK)/AKT/Matrix Metalloproteinase (MMP) Pathway.
Zhang P; Zhang H; Wang Y; Zhang P; Qi Y
Med Sci Monit; 2019 May; 25():3366-3373. PubMed ID: 31062766
[TBL] [Abstract][Full Text] [Related]
15. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the oncogenic activity of the novel TRIM59 gene in mouse cancer models.
Valiyeva F; Jiang F; Elmaadawi A; Moussa M; Yee SP; Raptis L; Izawa JI; Yang BB; Greenberg NM; Wang F; Xuan JW
Mol Cancer Ther; 2011 Jul; 10(7):1229-40. PubMed ID: 21593385
[TBL] [Abstract][Full Text] [Related]
17. TRIM59 is upregulated and promotes cell proliferation and migration in human osteosarcoma.
Liang J; Xing D; Li Z; Shen J; Zhao H; Li S
Mol Med Rep; 2016 Jun; 13(6):5200-6. PubMed ID: 27121462
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Tripartite-59 (TRIM59) Inhibits Cellular Proliferation and Migration in Human Cervical Cancer Cells.
Aierken G; Seyiti A; Alifu M; Kuerban G
Oncol Res; 2017 Mar; 25(3):381-388. PubMed ID: 27662486
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of tripartite motif-59 inhibits the malignant processes in human colorectal cancer cells.
Wu W; Chen J; Wu J; Lin J; Yang S; Yu H
Oncol Rep; 2017 Oct; 38(4):2480-2488. PubMed ID: 28849218
[TBL] [Abstract][Full Text] [Related]
20. TRIM59 knockdown inhibits cell proliferation by down-regulating the Wnt/β-catenin signaling pathway in neuroblastoma.
Chen G; Chen W; Ye M; Tan W; Jia B
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30389710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
